GT Biopharma, Inc. Share Price
NASDAQ: GTBP | Micro CapGT Biopharma, Inc. Stock Performance
Open $0.31 | Prev. Close $0.30 | Circuit Range N/A |
Day Range $0.31 - $0.33 | Year Range $0.27 - $1.80 | Volume 2,937 |
Average Traded $0.32 |
GT Biopharma, Inc. Share Price Today
As of 10 August 2026, GT Biopharma, Inc.'s share price is $0.32. The stock opened at $0.31, compared to its previous close of $0.30. During today's trading session, GT Biopharma, Inc.'s share price traded between $0.31 and $0.33, with an average price of $0.32. Over the past 52 weeks, the stock has recorded a high of $1.80 and a low of $0.27. In terms of performance, GT Biopharma, Inc.'s share price has declined by 31.71% over the last six months and is down 65.30% on a year-on-year basis.
GT Biopharma, Inc. Share Price Chart
GT Biopharma, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.77M | PE Ratio (TTM) -0.05 | Dividend Yield 12.49% |
EPS (TTM) $-6.68 | Revenue (TTM) N/A | Return On Equity (TTM) -489.96% |
Profit Margin N/A | Debt to Equity 0.40 | Quarterly Earnings Growth YoY 220.11% |
GT Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
GT Biopharma, Inc. Annual Profit & Loss
All figures in USD
About GT Biopharma, Inc.
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms. It develops GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias and an agonistic camelid; GTB-5550 that targets B7-H3 on the surface of advanced solid tumors; and GTB-7550, a product candidate in development for the treatment of lupus and other autoimmune disorders. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in San Francisco, California.
GT Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.30 | $0.32 | +9.59% |
Jul 2026 | $0.47 | $0.29 | -40.04% |
Jun 2026 | $0.49 | $0.49 | +1.67% |
May 2026 | $0.34 | $0.48 | +54.52% |
Apr 2026 | $0.41 | $0.31 | -25.48% |
Mar 2026 | $0.45 | $0.42 | -11.30% |
Feb 2026 | $0.65 | $0.47 | -29.26% |
Jan 2026 | $0.79 | $0.66 | -16.08% |
Dec 2025 | $0.77 | $0.79 | +0.00% |
Nov 2025 | $0.64 | $0.79 | +25.80% |
Oct 2025 | $0.62 | $0.63 | +6.62% |
Sep 2025 | $0.92 | $0.59 | -36.19% |
GTBP Share Price FAQs
What is GT Biopharma, Inc. share price today?
What is the 52 week high and 52 week low of GT Biopharma, Inc. stock?
What is GTBP's market capitalisation today?
What is GTBP's net income for the last quarter?
What is the 5 year returns of GTBP?
What is the high & low stock price of GTBP today?
Can I buy GTBP shares in India?